Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease

Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease

AIM: To study the role of the bone mineral metabolic mediators osteoprotegerin (OPG) and fibroblast growth factor 23 (FGF-23) in the mechanisms of cardiovascular events (CVEs) in chronic kidney disease (CKD)/MATERIAL AND METHODS: Sixty-eight patients (30 men and 38 women) aged 38 to 64 years (mean a...

Full description

Bibliographic Details
Main Authors: F U Dzgoeva, T M Gatagonova, T L Bestaeva, M Iu Sopoev, B G Bazaeva, O V Khamitsaeva
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2014-06-01
Series:Терапевтический архив
Subjects:
chronic kidney disease
bone mineral metabolic disturbances
cardiovascular events
osteoprotegerin
fibroblast growth factor 23
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31508

Internet

https://ter-arkhiv.ru/0040-3660/article/view/31508

Similar Items